Home

Welcome to the HealthTech Investor Day® by France Biotech, under the High Patronage of Mr Emmanuel MACRON president of the french Republic.

For the first time, France Biotech (The French Association of French HealthTech Entrepreneurs) is organizing a one-on-one meetings event to connect leading international investors, big pharma and top management innovative companies in HealthTech.

France Biotech has the ambition to make the city of Paris a European place for business meetings for international investors (European, American and Asian) and innovative HealthTech companies.

About the event

This HealthTech Investor Day®  will take place in Paris on June 25th , under the High Patronage of Mr Emmanuel MACRON President of the French Republic, with the support of the French and European health innovation ecosystem such as BPIFrance, Business Fance, EuropaBio, EIT Health; in partnership with banks, VC and pharmaceuticals companies.

This event is organized for private and listed companies willing to address leading investors and looking to raise funds.
Targeted companies: European innovative companies in HealthTech (biotech, medtech, digital-health) with a market-cap starting from €20 million (listed companies) and an on-going Phase 2 minimum for private biotech companies or CE or FDA approved product for medtech companies.

This event takes place at the Peninsula and includes:

  • One-on-one meetings between innovative HealthTech companies and investors: French, European, American, Asian and Saoudi Arabian hedge funds, VC, banks for near and long-term investment
  • Partnering meetings with big pharma such as Servier, Sanofi , Ipsen, Amgen, Novartis, Merck
  • Conferences and thematic panel discussions on specific topics:
  • France & Europe attractivity (speakers from Business France, BPIFrance and EuropaBio);
    Economy & Finance (speakers from the Nasdaq and Euronext);
    Importance of a BD strategy in the development of a HealthTech company (BDC Lifesciences);
    Promote France’s Strengths on Health Innovation (LIR Association);
    Hot topic in Oncology : After autologous CAR-T and Anti-PD1 / anti PD-L1 … what’s next?
    – Symbiotic relationship between Biotech and Pharmaceutical companies
    All those conferences will be supervised by a well-known international scientific patronage and Nobel Prize winner.
  • Glamorous event with special guests on Monday and Tuesday evening.

This unique day includes networking time so that all stakeholders can have the opportunity to meet.

More information: Contact us HERE

Program

BUSINESS PROGRAM

June 25th 2019 all day:
Where: Peninsula – 19 Avenue Kléber – 75116 Paris
When: From 7AM to 7PM
How: Link MeetMax – COMING SOON

  • One-on-one meetings (30 minutes each) between innovative HealthTech companies and investors: French, European, American, Asian and Saoudi Arabian hedge funds, VC, banks for near and long-term investment
  • Partnering meetings with big pharma such as Servier, Sanofi , Ipsen, Amgen, Novartis, Merck
  • Conferences and thematic panel discussions on specific topics:
    France & Europe attractivity (speakers from Business France, BPIFrance and EuropaBio);
    Economy & Finance (speakers from the Nasdaq and Euronext);
    Importance of a BD strategy in the development of a HealthTech company (BDC Lifesciences);
    Promote France’s Strengths on Health Innovation (LIR Association);
    Hot topic in Oncology : After autologous CAR-T and Anti-PD1 / anti PD-L1 … what’s next?
    Symbiotic relationship between Biotech and Pharmaceutical companies
    All those conferences will be supervised by a well-known international scientific patronage and Nobel Prize winner.

GLAMOROUS PROGRAM

June 24th 2019 evening:
Grand Opening Cocktail with special guests

June 25th 2019 evening:
Closure Cocktail with special guests

Attendees

If you are interested, please complete the survey here after :

February 7th: launch of the manifestation of interest to the French and European ecosystem;
March 14th: Deadline for receiving the companies’ application to participate;
April: Answer to companies regarding their participation;


You want to join us on June 25th but you are not a healthtech company?
Please complete the survey here after:

Contacts

Sophie Villedieu – France Biotech
Business Manager & US Communications
+33 (0)6 64 27 32 25
sophie.villedieu@france-biotech.org

With the assistance of Nathalie Donne in the organization
Nathalie Donne – Shape&Link
Co-founder and partner 
+33 (0) 6 67 67 44 97
nathalie.donne@shapenlink.com

Media contacts:
Caroline Carmagnole – Alize RP
CEO
+ 33 (0)1 44 54 36 66
France-biotech@alizerp.com

This event has been supervised by Maryvonne Hiance, Chairman of France Biotech